Publication & Citation Trends
Publications
0 total
Discovery of Insulin Receptor Partial Agonists MK-5160 and MK-1092 as Novel Basal Insulins with Potential to Improve Therapeutic Index.
Cited by 9
Semantic Scholar
Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists OA
Cited by 25
Semantic Scholar
High Resolution Episcopic Microscopy for Qualitative and Quantitative Data in Phenotyping Altered Embryos and Adult Mice Using the New “Histo3D” System OA
Cited by 10
Semantic Scholar
In Situ Forming Injectable Thermoresponsive Hydrogels for Controlled Delivery of Biomacromolecules OA
Cited by 64
Semantic Scholar
Molecular Profiling Reveals a Common Metabolic Signature of Tissue Fibrosis OA
Cited by 49
Semantic Scholar
Spatial and temporal studies of metabolic activity: contrasting biochemical kinetics in tissues and pathways during fasted and fed states. OA
Cited by 10
Semantic Scholar
Erratum. Engineering Glucose Responsiveness Into Insulin. Diabetes 2018;67:299–308 OA
Cited by 2
Semantic Scholar
Engineering Glucose Responsiveness Into Insulin
Cited by 59
Semantic Scholar
Research Topics
Receptor Mechanisms and Signaling
(9)
Metabolism, Diabetes, and Cancer
(8)
Diabetes Treatment and Management
(7)
Pancreatic function and diabetes
(6)
Peroxisome Proliferator-Activated Receptors
(6)
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States)
United States Military Academy
Quantitative BioSciences
Merck Institute for Science Education
Arena Pharmaceuticals (United States)